<p>Favipiravir Use in COVID-19: Analysis of Suspected Adverse Drug Events Reported in the WHO Database</p>-Reference-Cited by-同舟云学术

Favipiravir Use in COVID-19: Analysis of Suspected Adverse Drug Events Reported in the WHO Database

Published:2020-12 Issue: Volume:Volume 13 Page:4427-4438
ISSN:1178-6973
Container-title:Infection and Drug Resistance
language:en
Short-container-title:IDR

Author:

Kaur Rimple Jeet^ORCID,Charan Jaykaran^ORCID,Dutta Siddhartha^ORCID,Sharma Paras^ORCID,Bhardwaj Pankaj^ORCID,Sharma Praveen,Lugova Halyna^ORCID,Krishnapillai Ambigga,Islam Salequl^ORCID,Haque Mainul^ORCID,Misra Sanjeev

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Infectious Diseases,Pharmacology

Reference52 articles.

1. Current Status of Multiple Drug Molecules, and Vaccines: An Update in SARS-CoV-2 Therapeutics

2. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia

3. World Health Organization. WHO Director-General’s Opening Remarks at the Media Briefing on COVID-19-11 March 2020. Accessed October 2, 2020. https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19—11-march-2020.

4. First known person-to-person transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the USA

5. World Health Organization. WHO Coronavirus Disease (COVID-19) Dashboard [Updated Oct 4, 2020]. Accessed October 6, 2020. https://covid19.who.int/.

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Favipiravir‐induced bradycardia: A case report;Clinical Case Reports;2024-06-27

2. Self-reported side effects of COVID-19 vaccines among health professions students in India;PeerJ;2024-04-05

3. Extraction of Covid-19 drug (Favipiravir) from plasma samples by yolk-shell mesoporous silica before HPLC-MS/MS determination;Journal of Pharmaceutical and Biomedical Analysis;2024-02

4. Assessment of toxicological effects of favipiravir (T‐705) on the lung tissue of rats: An experimental study;Journal of Biochemical and Molecular Toxicology;2023-11-09

5. Drug Therapies against Acute Respiratory Distress: A Critical Endpoint of COVID-19;Medicinal Plants, Phytomedicines and Traditional Herbal Remedies for Drug Discovery and Development against COVID-19;2023-11-02